Faraaz Shah, MD
Dr. Shah rounds regularly in the medical and surgical intensive care units at the University Drive campus of the VA Pittsburgh while also conducting clinical and translational studies in sepsis with specific interests in nutrition and metabolism, cognitive function, and precision medicine approaches. Dr. Shah is funded on a K23 award and is a coinvestigator on several NIH-funded studies. He has served as the PI for the Convalescent Plasma and ACTIV-2 studies for COVID at VAPHS and has been a coinvestigator for numerous sepsis, ARDS, and COVID-19 clinical trials.
What are the 3 most important questions that define your research program?
- How do enteral nutrients affect inflammation and metabolism in sepsis?
- How do we uncover heterogeneity of treatment in sepsis and ARDS?
- What are the pathways contributing to long term cognitive dysfunction after critical illness?
What are five key words that best describe your areas of interest?
- Precision medicine
- Enteral nutrition
- Cognitive dysfunction
What are up to 5 technologies, models, methods, analytical approaches or other forms of expertise that characterize your research program?
- Clinical trials
- Supervised clustering
- Murine sepsis models (lipopolysaccharide, cecal ligation and puncture, pneumonia)
- Murine metabolic testing (glucose tolerance tests, insulin tolerance tests)
- Murine behavioral testing